PER 3.37% 8.6¢ percheron therapeutics limited

focus on anp

  1. 3,335 Posts.
    lightbulb Created with Sketch. 165
    Now we have finished with the ISIS antisence approval it is time to look at ANP's future.

    Today IMO due to the damage done over the past few days I believe ANP will open at 1.5c and struggle to close at 1.7c. That is unless we see a mass exodus of the current sellers. At this price ANP is a bargain with the major event still to come.

    ATL1103: ANP directors have consistently shown excitement over this product and shown that they are not prepared to give away a share of our asset cheaply and are prepared to go it alone on this one. In the event of that happening I am sure further offers would be looked at. At this point it is highly likely the board will soon be saying to our suitor that they have had sufficient time to come up with a suitable offer thus leaving it open for any other offers which I am sure will flow. In the meantime news of phase2 trial start should start to flow.

    ATL1102: Material should soon be available and news will start to flow on this including details on the JV Company.

    ATL1101: The board has indicated that they may be looking at a partnership on this one, my thinking is TJAB may be interested as they have indicated a desire to strengthen ties with ANP.

 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.6¢
Change
-0.003(3.37%)
Mkt cap ! $78.43M
Open High Low Value Volume
9.0¢ 9.0¢ 8.5¢ $55.51K 639.9K

Buyers (Bids)

No. Vol. Price($)
3 199624 8.5¢
 

Sellers (Offers)

Price($) Vol. No.
8.7¢ 272987 2
View Market Depth
Last trade - 11.51am 05/06/2024 (20 minute delay) ?
Last
8.7¢
  Change
-0.003 ( 2.25 %)
Open High Low Volume
8.7¢ 8.7¢ 8.5¢ 142260
Last updated 13.33pm 05/06/2024 ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.